News | October 21, 2024
Sunbird Bio raises additional US $14 million to advance Alzheimer blood tech test
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
Enhertu demonstrated clinically meaningful efficacy in previously treated patients
GBM affects nearly 13,000 patients annually in the US and approximately 300,000 globally
We now rank 3rd in pharmaceutical production by volume and 14th by value
Clarity in regulatory frameworks and pathways help in preventing delays in accessing quality-assured, affordable medicines
India’s first trial for a novel autologous BCMA directed CAR-T cell therapy in patients with relapsed / refractory multiple myeloma
Based on ECHO Phase III trial which demonstrated Calquence combination reduced risk of disease progression or death by 27% compared to standard-of-care chemoimmunotherapy
Sun Pharma will have the exclusive worldwide rights to commercialise Fibromun
Enzalutamide Tablets will be produced at the Group’s manufacturing site at SEZ, Ahmedabad
The authorization of bortezomib will enhance the company’s ability to deliver advanced cancer solutions in Southeast Asia
Subscribe To Our Newsletter & Stay Updated
